These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 3219249)

  • 21. Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate.
    Rapoport HS; Connolly JM; Fulmer J; Dai N; Murti BH; Gorman RC; Gorman JH; Alferiev I; Levy RJ
    Biomaterials; 2007 Feb; 28(4):690-9. PubMed ID: 17027944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triglycidyl amine crosslinking combined with ethanol inhibits bioprosthetic heart valve calcification.
    Connolly JM; Bakay MA; Alferiev IS; Gorman RC; Gorman JH; Kruth HS; Ashworth PE; Kutty JK; Schoen FJ; Bianco RW; Levy RJ
    Ann Thorac Surg; 2011 Sep; 92(3):858-65. PubMed ID: 21871270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new model to test the calcification characteristics of bioprosthetic heart valves.
    Ozaki S; Herijgers P; Flameng W
    Ann Thorac Cardiovasc Surg; 2004 Feb; 10(1):23-8. PubMed ID: 15008695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kangaroo versus freestyle stentless bioprostheses in a juvenile sheep model: hemodynamic performance and calcification behavior.
    Neethling WM; Hodge AJ; Glancy R
    J Card Surg; 2005; 20(1):29-34. PubMed ID: 15673407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility evaluation of a new pericardial bioprosthesis with dye mediated photo-oxidized bovine pericardial tissue.
    Bianco RW; Phillips R; Mrachek J; Witson J
    J Heart Valve Dis; 1996 May; 5(3):317-22. PubMed ID: 8793684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms.
    Vyavahare N; Hirsch D; Lerner E; Baskin JZ; Schoen FJ; Bianco R; Kruth HS; Zand R; Levy RJ
    Circulation; 1997 Jan; 95(2):479-88. PubMed ID: 9008467
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of different anticalcification treatments for stentless aortic bioprostheses.
    Walther T; Falk V; Diegeler A; Rauch T; Weigl C; Gummert J; Autschbach R; Mohr FW
    Thorac Cardiovasc Surg; 1999 Feb; 47(1):23-5. PubMed ID: 10218616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of calcification of bioprosthetic heart valves by local controlled-release diphosphonate.
    Levy RJ; Wolfrum J; Schoen FJ; Hawley MA; Lund SA; Langer R
    Science; 1985 Apr; 228(4696):190-2. PubMed ID: 3919445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of mechanical stress in calcification of aortic bioprosthetic valves.
    Thubrikar MJ; Deck JD; Aouad J; Nolan SP
    J Thorac Cardiovasc Surg; 1983 Jul; 86(1):115-25. PubMed ID: 6865456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Immune Responses and Calcification of Bioprostheses in the α1,3-Galactosyltransferase Knockout Mouse.
    Sung Jeong W; Jin Kim Y; Lim HG; Jung S; Ryul Lee J
    J Heart Valve Dis; 2016 Mar; 25(2):253-261. PubMed ID: 27989076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphologic findings in explanted Hancock II porcine bioprostheses.
    Butany J; Yu W; Silver MD; David TE
    J Heart Valve Dis; 1999 Jan; 8(1):4-15. PubMed ID: 10096476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of the long-term results of intra or extracardiac implanted bioprosthetic valves].
    Matsuno S; Yokota Y; Ando F; Okamoto F; Nakayama S; Ikeda T; Otani S
    Nihon Geka Gakkai Zasshi; 1995 Mar; 96(3):180-4. PubMed ID: 7731460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of calcification of bioprosthetic heart valve cusp and aortic wall with ethanol and aluminum chloride.
    Clark JN; Ogle MF; Ashworth P; Bianco RW; Levy RJ
    Ann Thorac Surg; 2005 Mar; 79(3):897-904. PubMed ID: 15734402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of fixation back pressure and antimineralization treatment on the morphology of porcine aortic bioprosthetic valves.
    Flomenbaum MA; Schoen FJ
    J Thorac Cardiovasc Surg; 1993 Jan; 105(1):154-64. PubMed ID: 8419696
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stentless valves treated by the L-hydro process in the aortic position in sheep.
    Santos PC; Gerola LR; Casagrande I; Buffolo E; Cheung DT
    Asian Cardiovasc Thorac Ann; 2007 Oct; 15(5):413-7. PubMed ID: 17911070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemodynamic and pathologic evaluation of a unileaflet pericardial bioprosthetic valve.
    Shemin RJ; Schoen FJ; Hein R; Austin J; Cohn LH
    J Thorac Cardiovasc Surg; 1988 May; 95(5):912-9. PubMed ID: 3361939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The future of bioprosthetic valves. A pathologist's perspective.
    Schoen FJ
    ASAIO Trans; 1988; 34(4):1040-2. PubMed ID: 3064786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placement of aortic valve bioprostheses in sheep via a left thoracotomy. Implantation of stentless porcine heterografts.
    Brown WM; Jay JL; Gott JP; Pan-Chih ; Dorsey LM; Churchwell A; Guyton RA
    ASAIO Trans; 1991; 37(3):M445-6. PubMed ID: 1751230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization.
    Schoen FJ; Tsao JW; Levy RJ
    Am J Pathol; 1986 Apr; 123(1):134-45. PubMed ID: 2421577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a next-generation tissue valve using a glutaraldehyde-fixed porcine aortic valve treated with decellularization, α-galactosidase, space filler, organic solvent and detoxification.
    Lim HG; Kim GB; Jeong S; Kim YJ
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):104-13. PubMed ID: 25315752
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.